Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Washington University School of Medicine
With
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Age
7–16
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
LO5:
Between the ages of 7 and 16
Diagnosed with type 1 diabetes within 3 months
Between the ages of 7 and 16
You may not be if
Pregnant or lactating
Chronic disease other than T1DM, well-controlled asthma, or Hashimoto's thyroiditis
Other current serious medical illness
Psychiatric illness
Psychoactive drug dependence
Neurological illness (except T1DM-related): stroke, seizure, major loss of consciousness, head injuries, encephalitis, or hydrocephalus, blindness, deafness
Use of psychoactive medications or exposure to neuroleptics (except that exposures of less than 1 month, occurring more than 5 years ago, will be allowed)
Use of dopamine depleting agents or stimulants such as Ritalin, Cylert, Adderall
Pre-maturity at birth of more than 4 wks early with complications (e.g. on respirator at NICU)
Inability to complete MRI scan (e.g. claustrophobia, metal implants)
Full set (top and bottom) of orthodontic braces (Half set braces, fillings, and retainers are OK)
Same as above (except cannot have type 1 diabetes)
HY5: Must have been a participant in our earlier study.
Clareo Health | Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)
